Methods of using FIX polypeptides

US11193116B2 · kind B2 · utility

Assignee

• BIOVERATIV THERAPEUTICS INC. · US

Inventors

• Glenn Pierce · Cambridge, US
• Samantha Truex · Sudbury, US
• Robert T. Peters · Needham, US
• Haiyan Jiang · Belmont, US
• Mark Brader · Cambridge, US

Key dates

• Filing date: Jun 9, 2017
• Grant date: Dec 7, 2021
• Expiry date: Jul 25, 2038

Classification

• Technology area (CPC —): General

Abstract

The present invention provides methods of administering long-acting Factor IX; methods of administering long-acting, chimeric and hybrid polypeptides comprising Factor IX; and methods of producing such chimeric and hybrid polypeptides using cells.